The Valley Desk

NCT00441090 · Interventional trial

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Overall registry status Completed

Phase 2

Conditions Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov